Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31).
Publication
, Journal Article
Shen, LL; Del Priore, LV
Published in: Ophthalmol Retina
February 2024
Duke Scholars
Published In
Ophthalmol Retina
DOI
EISSN
2468-6530
Publication Date
February 2024
Volume
8
Issue
2
Start / End Page
e3
Location
United States
Related Subject Headings
- Retina
- Peptides, Cyclic
- Humans
- Geographic Atrophy
- Cost-Effectiveness Analysis
Citation
APA
Chicago
ICMJE
MLA
NLM
Shen, L. L., & Del Priore, L. V. (2024). Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31). Ophthalmol Retina, 8(2), e3. https://doi.org/10.1016/j.oret.2023.09.019
Shen, Liangbo Linus, and Lucian V. Del Priore. “Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31).” Ophthalmol Retina 8, no. 2 (February 2024): e3. https://doi.org/10.1016/j.oret.2023.09.019.
Shen LL, Del Priore LV. Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31). Ophthalmol Retina. 2024 Feb;8(2):e3.
Shen, Liangbo Linus, and Lucian V. Del Priore. “Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31).” Ophthalmol Retina, vol. 8, no. 2, Feb. 2024, p. e3. Pubmed, doi:10.1016/j.oret.2023.09.019.
Shen LL, Del Priore LV. Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31). Ophthalmol Retina. 2024 Feb;8(2):e3.
Published In
Ophthalmol Retina
DOI
EISSN
2468-6530
Publication Date
February 2024
Volume
8
Issue
2
Start / End Page
e3
Location
United States
Related Subject Headings
- Retina
- Peptides, Cyclic
- Humans
- Geographic Atrophy
- Cost-Effectiveness Analysis